A detailed history of Alliancebernstein L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Alliancebernstein L.P. holds 4,163,134 shares of ABT stock, worth $483 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
4,163,134
Previous 3,201,052 30.06%
Holding current value
$483 Million
Previous $333 Million 42.7%
% of portfolio
0.17%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $96.3 Million - $114 Million
962,082 Added 30.06%
4,163,134 $475 Million
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $95.8 Million - $107 Million
-951,049 Reduced 22.91%
3,201,052 $333 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $585 Million - $646 Million
-5,337,958 Reduced 56.25%
4,152,101 $472 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $126 Million - $154 Million
-1,392,719 Reduced 12.8%
9,490,059 $1.04 Billion
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $68.8 Million - $82.5 Million
720,015 Added 7.08%
10,882,778 $1.05 Billion
Q2 2023

Aug 15, 2023

BUY
$100.78 - $112.29 $91.9 Million - $102 Million
911,942 Added 9.86%
10,162,763 $1.11 Billion
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $3.48 Million - $4.09 Million
-35,907 Reduced 0.39%
9,250,821 $937 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $275 Million - $323 Million
-2,895,139 Reduced 23.77%
9,286,728 $1.02 Billion
Q3 2022

Nov 15, 2022

SELL
$96.76 - $112.03 $9.35 Million - $10.8 Million
-96,668 Reduced 0.79%
12,181,867 $1.18 Billion
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $60.3 Million - $72.9 Million
-590,755 Reduced 4.59%
12,278,535 $1.33 Billion
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $77 Million - $93.9 Million
-675,329 Reduced 4.99%
12,869,290 $1.52 Billion
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $9.8 Million - $12 Million
-84,807 Reduced 0.62%
13,544,619 $1.91 Billion
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $75.5 Million - $83.5 Million
646,920 Added 4.98%
13,629,426 $1.61 Billion
Q2 2021

Jul 30, 2021

BUY
$105.79 - $124.53 $8.92 Million - $10.5 Million
84,274 Added 0.65%
12,982,506 $1.51 Billion
Q1 2021

May 06, 2021

SELL
$108.84 - $128.23 $48.8 Million - $57.4 Million
-448,021 Reduced 3.36%
12,898,232 $1.55 Billion
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $17.5 Million - $19 Million
166,232 Added 1.26%
13,346,253 $1.46 Billion
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $52.7 Million - $63.9 Million
574,569 Added 4.56%
13,180,021 $1.43 Billion
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $9.07 Million - $11.6 Million
118,392 Added 0.95%
12,605,452 $1.15 Billion
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $99.6 Million - $146 Million
-1,585,315 Reduced 11.27%
12,487,060 $985 Million
Q4 2019

Feb 18, 2020

BUY
$78.51 - $87.4 $47.9 Million - $53.3 Million
610,015 Added 4.53%
14,072,375 $1.22 Billion
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $65 Million - $70.5 Million
-794,033 Reduced 5.57%
13,462,360 $1.13 Billion
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $27.3 Million - $31.8 Million
374,235 Added 2.7%
14,256,393 $1.2 Billion
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $22.7 Million - $27.5 Million
-343,072 Reduced 2.41%
13,882,158 $1.11 Billion
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $10.8 Million - $12.2 Million
-163,999 Reduced 1.14%
14,225,230 $1.03 Billion
Q3 2018

Nov 08, 2018

SELL
$60.81 - $73.36 $70.8 Million - $85.4 Million
-1,163,653 Reduced 7.48%
14,389,229 $1.06 Billion
Q2 2018

Aug 13, 2018

BUY
$57.57 - $63.54 $51 Million - $56.3 Million
886,585 Added 6.05%
15,552,882 $949 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $124 Million - $140 Million
2,203,794 Added 17.68%
14,666,297 $879 Million
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $5.42 Million - $5.81 Million
-101,061 Reduced 0.8%
12,462,503 $711 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $604 Million - $674 Million
12,563,564
12,563,564 $670 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.